IFP Advisors
KYMR icon

IFP Advisors’s Kymera Therapeutics KYMR Stock Holding History

IFP Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$82.4K Buy
737
+518
+237% +$59.3K ﹤0.01% 2088
2026
Q2 		$25.1K Buy
219
+22
+11% +$1.89K ﹤0.01% 2836
2026
Q1 		$16.4K Buy
197
+12
+6% +$950 ﹤0.01% 2880
2025
Q4 		$14.4K Hold
185
– – ﹤0.01% 2885
2025
Q3 		$10.5K Buy
185
+116
+168% +$5.23K ﹤0.01% 2882
2025
Q2 		$13.1K Buy
+69
New +$2.38K ﹤0.01% 2767
2025
Q1 		– Hold
0
– – – 3915
2024
Q4 		– Hold
0
– – – 3965

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

IFP Advisors's KYMR Position: Q3 2026 in Review

IFP Advisors increased its Kymera Therapeutics (KYMR) stake by 237% in Q3 2026, buying an estimated $59.3K and bringing the position to 737 shares worth $82.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2088.

IFP Advisors first reported a position in KYMR in Q2 2025 and has held it in 6 quarters since. 173 funds tracked by Wall St. Rank hold KYMR as of Q3 2026.

  • IFP Advisors held 737 shares of Kymera Therapeutics worth $82.4K as of Q3 2026.
  • IFP Advisors bought 518 Kymera Therapeutics shares in Q3 2026, an estimated $59.3K.
  • Kymera Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2088 holding.
  • IFP Advisors first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • 173 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.